Skip to main content

Inflammatory Bowel Disease

  • Chapter
  • First Online:
The Perioperative Medicine Consult Handbook
  • 2809 Accesses

Abstract

Despite the widespread use of medical therapy in the management of inflammatory bowel disease (IBD), up to 30 % of patients with ulcerative colitis (UC) and 70 % of patients with Crohn’s disease (CD) will require intra-abdominal surgery. Patients with IBD are at risk for postoperative complications including surgical site infection, intra-abdominal abscess, bacteremia, strictures and fistulae, small bowel obstruction, portal vein thrombosis, and poor wound healing including anastomotic leak and wound dehiscence.

This chapter focuses on evidence for IBD patients undergoing intra-abdominal surgery; however, the medication recommendations are applicable for IBD patients undergoing other types of surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Narula N, Charleton D, Marshall JK. Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;37(11):1057–64. doi:10.1111/apt.12313.

    Article  CAS  PubMed  Google Scholar 

  2. Nasir BS, Dozois EJ, Cima RR, et al. Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn’s disease. J Gastrointest Surg. 2010;14(12):1859–66. doi:10.1007/s11605-010-1341-5.

    Article  PubMed  Google Scholar 

  3. Appau KA, Fazio VW, Shen B, et al. Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn’s patients. J Gastrointest Surg. 2008;12(10):1738–44. doi:10.1007/s11605-008-0646-0.

    Article  PubMed  Google Scholar 

  4. Bafford AC, Powers S, Ha C, et al. Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease. J Clin Gastroenterol. 2013;47(6):491–5. doi:10.1097/MCG.0b013e3182677003.

    Article  PubMed  Google Scholar 

  5. Beddy D, Dozois EJ, Pemberton JH. Perioperative complications in inflammatory bowel disease. Inflamm Bowel Dis. 2011;17(7):1610–9. doi:10.1002/ibd.21504.

    Article  PubMed  Google Scholar 

  6. Kunitake H, Hodin R, Shellito PC, Sands BE, Korzenik J, Bordeianou L. Perioperative treatment with infliximab in patients with Crohn’s disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg. 2008;12(10):1730–7. doi:10.1007/s11605-008-0630-8.

    Article  PubMed  Google Scholar 

  7. Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infection and mortality in patients with Crohn’s disease: more than 5 years of follow-up in the TREAT™ registry. Am J Gastroenterol. 2012;107(9):1409–22. doi:10.1038/ajg.2012.218.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Kumar A, Auron M, Aneja A, Mohr F, Jain A, Shen B. Inflammatory bowel disease: perioperative pharmacological considerations. Mayo Clin Proc. 2011;86(8):748–57. doi:10.4065/mcp.2011.0074.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Sewell JL, Mahadevan U. Infliximab and surgical complications: truth or perception? Gastroenterology. 2009;136(1):354–5. doi:10.1053/j.gastro.2008.11.057.

    Article  PubMed  Google Scholar 

  10. Ali T. Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease. WJG. 2012;18(3):197. doi:10.3748/wjg.v18.i3.197.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Nørgård BM, Nielsen J, Qvist N, Gradel KO, de Muckadell OBS, Kjeldsen J. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease – a nationwide cohort study. Aliment Pharmacol Ther. 2012;37(2):214–24. doi:10.1111/apt.12159.

    Article  PubMed  Google Scholar 

  12. Nørgård BM, Nielsen J, Qvist N, Gradel KO, Muckadell OBS, Kjeldsen J. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with ulcerative colitis – a nationwide cohort study. Aliment Pharmacol Ther. 2012;35(11):1301–9. doi:10.1111/j.1365-2036.2012.05099.x.

    Article  PubMed  Google Scholar 

  13. Singh S, Graff LA, Bernstein CN. Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD? Am J Gastroenterol. 2009;104(5):1298–314. doi:10.1038/ajg.2009.15.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gabrielle Berger M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Berger, G. (2015). Inflammatory Bowel Disease. In: Jackson, M.B., Mookherjee, S., Hamlin, N.P. (eds) The Perioperative Medicine Consult Handbook. Springer, Cham. https://doi.org/10.1007/978-3-319-09366-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-09366-6_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-09365-9

  • Online ISBN: 978-3-319-09366-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics